Human Gene Therapy

Hum Gene Ther

1043-0342

1557-7422

Therapeutic Area

Biology, Biotechnology, Cytology/Cell Biology, Genomics, Molecular Medicine, Research

Academicians, Biologists, Cell Biologists, Cytologists/Cell Biologists, Microbiologists, Molecular Biologists, Researchers, Scientists

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases. Complete HGT Program coverage includes: Improvements in vector developments, Delivery systems, Cell therapy, Small nucleic acid therapeutics, including RNAi, Clinical trials and animal models, Clinical protocols, Pre-clinical animal and in vitro studies to assess the safety of gene and cell therapy products used to support clinical applications, Clinical trials including those in which the results are confirmatory or negative, Topical issues related to the commercial development of gene and cell therapy products.

European Society of Gene and Cell Therapy (ESGCT)

Mary Ann Liebert, Inc.

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines